Swiss - Delayed Quote CHF
Newron Pharmaceuticals S.p.A. (NWRN.SW)
At close: 5:30 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Cash Flow
-10,140.00
-10,140.00
-11,092.00
-11,445.00
-15,588.00
--
Investing Cash Flow
3,246.00
3,246.00
-317.00
8,420.00
-616.00
--
Financing Cash Flow
-192.00
-192.00
-186.00
14,831.00
7,365.00
--
End Cash Position
6,338.00
6,338.00
13,424.00
25,019.00
13,213.00
--
Capital Expenditure
-11.00
-11.00
-18.00
-20.00
-35.00
--
Issuance of Debt
--
--
--
15,000.00
7,500.00
17,500.00
Free Cash Flow
-10,151.00
-10,151.00
-11,110.00
-11,465.00
-15,623.00
--
12/31/2019 - 12/11/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MOLN.SW Molecular Partners AG
5.80
+1.75%
IDIA.SW Idorsia Ltd
1.1700
-2.26%
RLF.SW Relief Therapeutics Holding SA
5.72
-6.23%
SANN.SW Santhera Pharmaceuticals Holding AG
8.99
-1.96%
SPEX.SW Spexis AG
0.0570
0.00%
ADXN.SW Addex Therapeutics Ltd
0.0840
+6.06%
EVE.SW Evolva Holding SA
0.8800
+8.64%
ONWD.BR Onward Medical N.V.
5.72
-4.98%
BION.SW BB Biotech AG
37.95
+0.53%
MEB.F MedinCell S.A.
15.62
-1.14%